September 22, 2017 7:20 PM ET

Biotechnology

Company Overview of OvaScience, Inc.

Company Overview

OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women worldwide. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize the fertility treatment consisting of AUGMENT to enhance the energy and health of the woman’s eggs by using mitochondria from a woman's EggPC cells; OvaTure to produce mature fertilizable eggs from a woman’s own EggPC cells without the need for hormone inject...

9 Fourth Avenue

Waltham, MA 02451

United States

Founded in 2011

118 Employees

Phone:

617-500-2802

Key Executives for OvaScience, Inc.

Co-Founder & Advisor
Age: 41
Total Annual Compensation: $811.8K
Compensation as of Fiscal Year 2016.

OvaScience, Inc. Key Developments

OvaScience, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017

OvaScience, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. Revenue for the quarter ended June 30, 2017 was $84,000, compared to $189,000 for the same period in 2016. Net loss for the quarter ended June 30, 2017 was $18.2 million, or $0.51 per share, compared to a net loss of $18.6 million, or $0.62 per share, for the same period in 2016. The net loss for the quarter ended June 30, 2017 includes restructuring charges of $2.0 million. Loss from operations was $17.930 million against $18.241 million a year ago. Loss before income taxes was $18.173 million against $18.518 million a year ago. For the six months, the company reported revenue of $147,000 against $335,000 a year ago. Loss from operations was $33.008 million against $39.680 million a year ago. Loss before income taxes was $33.550 million against $40.201 million a year ago. Net loss was $33.572 million or $0.94 per basic and diluted share against $40.326 million or $1.41 per basic and diluted share a year ago.

OvaScience, Inc., Q2 2017 Earnings Call, Aug 03, 2017

OvaScience, Inc., Q2 2017 Earnings Call, Aug 03, 2017

OvaScience, Inc. Cuts Half of Its Staff

OvaScience layoffs half of its employees on June 21, 2017, as it gives birth to a new business strategy focused on developing new treatments for fertility rather than commercializing its existing one.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OvaScience, Inc., please visit www.ovascience.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.